BCG treatment of malignant pleural effusions in the rat.
Intrapleurally injected cells of an ascitic rat tumour produced intrapleural effusions and solid pleural deposits. BCG, or its methanol extraction residue (MER) injected into the pleural space, suppressed tumour development and prolonged survival. Treatment was effective if given a few days before or after tumour injection. In contrast, active specific immunotherapy by repeated s.c. injection of viable or radiation-attenuated tumour cells in admixture with BCG was unsuccessful, and  did not improve the response to intrapleural BCG treatment.
D000818:Animals; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D008113:Liver Neoplasms; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000628:therapy*; D010994:Pleura; D010996:Pleural Effusion / Q000209:etiology / Q000517:prevention & control*; D010997:Pleural Neoplasms / Q000150:complications; D051381:Rats; D013997:Time Factors
D000951:Antigens, Neoplasm; D001500:BCG Vaccine